Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'p53 and mdm2 proteins interaction inhibitor racemic'

Search results for: 'p53 and mdm2 proteins interaction inhibitor racemic'

Items 31-40 of 105

Page
per page
  1. 3-Deazaneplanocin A (DZNep) hydrochloride
    A8182 3-Deazaneplanocin A (DZNep) hydrochloride
     1 Citation
    Target: EZH2
    Summary: SAHH and EZH2 inhibitor
      insoluble in EtOH; ≥14.94 mg/mL
  2. PJ34
    A3729 PJ34
    Target: PARP
    Summary: PARP-l inhibitor
      ≥50.9 mg/mL
  3. AZD2461
    A4164 AZD2461
    Target: PARP
    Summary: Novel PARP inhibitor
      insoluble in H2O; ≥16.35 mg/mL
  4. GLPG0634
    B1130 GLPG0634
     1 Citation
    Target: JAK
    Summary: JAK1 inhibitor
      ≥21.3 mg/mL
  5. CI994 (Tacedinaline)
    A4102 CI994 (Tacedinaline)
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in H2O; insoluble in EtOH; ≥50 mg/mL
  6. Lomeguatrib
    A1912 Lomeguatrib
    Target: O6-methylguanine-DNA-methyl-transferase (MGMT)
    Summary: MGMT inhibitor
      ≥50 mg/mL
  7. RG2833
    A3761 RG2833
    Target: HDAC
    Summary: Brain-penetrant HDAC inhibitor
      insoluble in H2O; ≥16.95 mg/mL
  8. Valproic acid
    B1251 Valproic acid
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC1 inhibitor
      ≥12.35 mg/mL
  9. MS436
    B1012 MS436
    Target: Bromodomains
    Summary: BRD4 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥19.15 mg/mL
  10. SMI-4a
    A4193 SMI-4a
    Target: Pim
    Summary: Potent Pim inhibitor
      insoluble in H2O; ≥13.65 mg/mL

Items 31-40 of 105

Page
per page
Shop By
Now Shopping by
  1. Category Chromatin/Epigenetics Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Bromodomain 10item
  2. Aurora Kinase 13item
  3. DNA Methyltransferase 4item
  4. HDAC 27item
  5. Histone Acetyltransferases 4item
  6. Histone Demethylases 2item
  7. Histone Methyltransferase 15item
  8. HIF 3item
  9. JAK 12item
  10. PARP 6item
  11. Pim 3item
  12. Protein Ser/Thr Phosphatases 3item
  13. Sirtuin 3item
  14. Sphingosine Kinase-2 1 item
Reversibility
  1. Reversible 7item
  2. Irreversible 1 item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Histone Deacetylases (HDACs) 25item
  3. PI3K 1 item
  4. Aurora Kinases 13item
  5. EZH2 3item
  6. Bromodomains 5item
  7. FLT3 1 item
  8. Hydrolase 1 item
  9. MEK 1 item
  10. DOT1L 3item
  11. Nrf2 1 item
  12. Pim 3item
  13. Sir2-like Family Deacetylases (Sirtuins) 2item
  14. PP1 1 item
  15. PP2A 1 item
  16. Src 1 item
  17. STAT 1 item
  18. Hypoxia Inducible Factors (HIFs) 2item
  19. Tankyrases 1 item
  20. JAK 11item
  21. p300 1 item
  22. Syk 1 item
  23. EZH1 1 item
  24. TNKS 1 item
  25. Topoisomerases 1 item
  26. DNA Methyltransferases 3item
  27. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs) 1 item
  28. SMYD2 1 item
  29. CREBBP 2item
  30. EP300 2item
  31. PARP 4item
  32. Bromodomain and Extra-Terminal motif (BET) 1 item
  33. phosphatases 1 item
  34. NAT10 1 item
  35. G9a 2item
  36. SETD7 1 item
  37. AChE 1 item
  38. Catechol O-Methyltransferase (COMT) 1 item
  39. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  40. Protein Arginine Methyltransferases 1 item
  41. Cytidine deaminases 1 item
  42. PP4 1 item
  43. c-RET 1 item
  44. Protein polybromo-1 1 item
  45. SMARCA4 1 item
  46. SMARCA2 1 item
  47. HDAC 1 item
  48. Histone Acetyltransferases (HATs) 1 item
  49. TYK2 1 item
  50. Lck 1 item
  51. LSD 1 item
  52. PRMT 1 item
  53. GLP 1 item
  54. SK 1 item
  55. Sirtuin 1 item
Reported Experiments
  1. Animal Experiments 85item
  2. Cell Experiments 62item
Related Disease
  1. Acute Myelogenous Leukemia 2item
  2. Acute Myeloid Leukemia 8item
  3. Bladder Cancer 2item
  4. Bladder Carcinoma 1 item
  5. Breast Cancer 18item
  6. Cancer 64item
  7. Castration-resistant Prostate Cancer 1 item
  8. Cervical Cancer 1 item
  9. Chronic Lymphocytic Leukemia 1 item
  10. Colon Cancer 10item
  11. Colon Carcinoma 1 item
  12. Colorectal Cancer 5item
  13. Diabetes 1 item
  14. Diffuse Large B-cell Lymphoma 1 item
  15. Dyskinesia 1 item
  16. Epilepsy 1 item
  17. Friedreich's Ataxia 1 item
  18. Glioblastoma 2item
  19. Glioma 2item
  20. Hepatic Cancer 1 item
  21. Hepatocellular Carcinoma 1 item
  22. HIV Infections 2item
  23. Immunological Diseases 1 item
  24. Inflammatory Bowel Disease 1 item
  25. Inflammatory Diseases 2item
  26. Leukemia 7item
  27. Lung Cancer 6item
  28. Lymphoma 6item
  29. Melanoma 5item
  30. Mixed Lineage Leukemia 3item
  31. Multiple Myeloma 5item
  32. Myelofibrosis 1 item
  33. Myeloma 1 item
  34. Neuroblastoma 2item
  35. Neuronal Protection 1 item
  36. Non-small Cell Lung Cancer 5item
  37. Ovarian Cancer 5item
  38. Pancreatic Cancer 4item
  39. Prostate Cancer 12item
  40. Psoriasis 1 item
  41. Renal Cancer 1 item
  42. Renal Cell Carcinoma 2item
  43. Rheumatoid Arthritis 3item
  44. Thyroid Cancer 1 item